RXI Pharma (RXII) Tops Q2 EPS by 2c

August 11, 2016 7:04 AM EDT
Get Alerts RXII Hot Sheet
Trade RXII Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

RXI Pharma (NASDAQ: RXII) reported Q2 EPS of ($0.34), $0.02 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $9 thousand, versus $0 reported last year.

For earnings history and earnings-related data on RXI Pharma (RXII) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment